Canada breast cancer diagnostics market is estimated to grow significantly at a CAGR of around 11.5% during the forecast period. The factors that influence the market growth in Canada include increasing the screening test for breast cancer and prevalence due to changes in life style. Breast cancer is the second leading cause of mortality in Canada. The incidence rate of breast cancer in Canada slightly increase with the increase in years. According to the Canadian Cancer Society about 26,300 women diagnosed with breast cancer in 2017. This accounts for 25% of all new cancer cases in women. The mortality due to breast cancer was about 5,000, which is 13% of all cancer mortality in women. On average 72 women in Canada were diagnosed and 14 women died with breast cancer every day. The breast cancer also happened in men about 230 men were diagnosed and mortality about 60 from breast cancer in 2017.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/canada-breast-cancer-diagnostics-market
Canada breast cancer diagnostics market is segmented on the basis of technology. Based on technology, the market is further classified into mammography, biopsy, position emission tomography/Computed tomography, ultrasound, and others. The mammography segment is projected to hold the largest share in the market. Mammography is a specific medical imaging technique that uses a low-dose x-ray system to see inside the breasts. A mammography exam, called a mammogram, aids in the early detection and diagnosis of breast diseases in women. The end-user segment market is further segregated into hospitals and diagnostics centers.
The companies which are contributing to the growth of the Canada breast cancer diagnostics market include Agendia NV, Becton, Dickinson and Co., Danaher Corp., General Electric Co., Hologic Inc., Johnson & Johnson Services Inc., Myriad Genetics, Inc., NanoString Technologies, Inc., Koninklijke Philips N.V., Siemens Healthcare GmbH, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, and technological advancements to stay competitive in the market.
A full report of Canada Breast Cancer Diagnostics Market available @ https://www.omrglobal.com/industry-reports/canada-breast-cancer-diagnostics-market
Canada Breast Cancer Diagnostics Market Segmentation
By Technology
- Mammography
- Biopsy
- PET/CET
- Ultrasound
- Others (MRI)
By End-User
- Hospitals
- Diagnostics Centers
Company Profiles
- Agendia NV
- Becton, Dickinson and Co.
- Danaher Corp.
- General Electric Co.
- Hologic Inc.
- Johnson & Johnson Services Inc.
- Myriad Genetics, Inc.
- NanoString Technologies, Inc.
- Koninklijke Philips N.V.,
- Siemens Healthcare GmbH
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
